Jingnian Ni
- Neurology top 10%
- Neurological Disease Mechanisms and Treatments 4
- Parkinson's Disease Mechanisms and Treatments 2
- Neurological Disorders and Treatments 2
- Psychiatry and Mental health top 10%
- Dementia and Cognitive Impairment Research 10
-
- Medicinal Plants and Neuroprotection 4
- Ginkgo biloba and Cashew Applications 3
-
- Alzheimer's disease research and treatments 11
-
- Cholinesterase and Neurodegenerative Diseases 5
- Journals
- SHILAP Revista de lepidopterología (1 paper)Journal of the American Geriatrics Society (1 paper)Medicine (2 papers)
- Partner nations
- ChinaUnited KingdomAustralia
In The Last Decade
Jingnian Ni
30 papers receiving 358 citations
Peers
Comparison fields: 5 of 87
- Neurology 77
- Psychiatry and Mental health 112
- Biological Psychiatry 18
- Complementary and alternative medicine 52
- Sensory Systems 19
Countries citing papers authored by Jingnian Ni
This map shows the geographic impact of Jingnian Ni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingnian Ni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingnian Ni more than expected).
Fields of papers citing papers by Jingnian Ni
This network shows the impact of papers produced by Jingnian Ni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingnian Ni. The network helps show where Jingnian Ni may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jingnian Ni, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 3 | |
| 5 | 2024 | 4 | |
| 6 | 2024 | 3 | |
| 7 | 2023 | 4 | |
| 8 | 2022 | 15 | |
| 9 | 2022 | 27 | |
| 10 | 2022 | 18 | |
| 11 | 2022 | 12 | |
| 12 | 2019 | 18 | |
| 13 | 2019 | 7 | |
| 14 | 2019 | 6 | |
| 15 | 2017 | 10 | |
| 16 | 2017 | 3 | |
| 17 | 2017 | 41 | |
| 18 | 2016 | 14 | |
| 19 | 2014 | 26 | |
| 20 | 2013 | 5 |
About Jingnian Ni
Jingnian Ni is a scholar working on Complementary and alternative medicine, Neurology and Psychiatry and Mental health, having authored 34 papers that have together received 363 indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (11 papers), Dementia and Cognitive Impairment Research (10 papers), Cholinesterase and Neurodegenerative Diseases (5 papers), Medicinal Plants and Neuroprotection (4 papers), Neurological Disease Mechanisms and Treatments (4 papers), Ginkgo biloba and Cashew Applications (3 papers), Parkinson's Disease Mechanisms and Treatments (2 papers) and Neurological Disorders and Treatments (2 papers). The work is most often cited by research in Neurology (77 citations), Psychiatry and Mental health (112 citations) and Biological Psychiatry (18 citations). Jingnian Ni has collaborated with scholars based in China, United Kingdom and Australia. Frequent co-authors include Mingqing Wei, Jinzhou Tian, Jing Shi, Yongyan Wang, Xuekai Zhang, Dongsheng Fan, Ting Li, Xuekai Zhang, Bin Qin and Yumeng Li. Their work appears in journals such as SHILAP Revista de lepidopterología, Journal of the American Geriatrics Society and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.